A detailed history of Woodline Partners LP transactions in Absci Corp stock. As of the latest transaction made, Woodline Partners LP holds 2,090,801 shares of ABSI stock, worth $6.59 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,090,801
Previous 1,475,076 41.74%
Holding current value
$6.59 Million
Previous $4.54 Million 75.79%
% of portfolio
0.07%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.97 - $4.49 $1.83 Million - $2.76 Million
615,725 Added 41.74%
2,090,801 $7.99 Million
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $2,601 - $5,862
891 Added 0.06%
1,475,076 $4.54 Million
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $5.03 Million - $8.46 Million
1,474,185 New
1,474,185 $8.37 Million
Q4 2021

Feb 14, 2022

SELL
$7.88 - $18.03 $1.38 Million - $3.16 Million
-175,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $1.81 Million - $5.3 Million
175,000 New
175,000 $2.04 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $292M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.